| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $5.4M | +50.0% |
| SG&A Expense | $5.3M | +14.3% |
| Operating Income | -$16.9M | -106.3% |
| Interest Expense | $7K | +63.7% |
| Pre-tax Income | -$16.7M | -106.7% |
| Income Tax | -$305K | -2628.3% |
| Net Income | -$16.4M | -102.6% |
| EPS (Basic) | -$1.77 |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.9M | +562.5% |
| Current Assets | $9.0M | +396.7% |
| Total Assets | $18.1M | +19.1% |
| Current Liabilities | $1.6M | -9.2% |
| Long-term Debt | $278K | +0.0% |
| Total Liabilities | $8.8M | +8.3% |
| Stockholders' Equity | $9.2M | +31.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.9M | -48.8% |
| Capital Expenditures | $64K | +218.1% |
| Investing Cash Flow | -$157K | +35.8% |
| Financing Cash Flow | $17.8M | +256.1% |
| Free Cash Flow | -$11.0M | -49.3% |
| +0.0% |
| EPS (Diluted) | -$1.77 | +0.0% |